Recent Advances in Three-Dimensional In Vitro Models for Studies of Liver Fibrosis

  • Kyun Yoo Chi
  • , Gyeongmin Kim
  • , Jeong Sang Son
  • , Jiyou Han
  • , Jong Hoon Kim*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: Liver fibrosis is a reversible but complex pathological condition associated with chronic liver diseases, affecting over 1.5 billion people worldwide. It is characterized by excessive extracellular matrix deposition resulting from sustained liver injury, often advancing to cirrhosis and cancer. As its progression involves various cell types and pathogenic factors, understanding the intricate mechanisms is essential for the development of effective therapies. In this context, extensive efforts have been made to establish three-dimensional (3D) in vitro platforms that mimic the progression of liver fibrosis. Methods: This review outlines the pathophysiology of liver fibrosis and highlights recent advancements in 3D in vitro liver models, including spheroids, organoids, assembloids, bioprinted constructs, and microfluidic systems. It further assesses their biological relevance, with particular focus on their capacity to reproduce fibrosis-related characteristics. Results: 3D in vitro liver models offer significant advantages over conventional two-dimensional cultures. Although each model exhibits unique strengths, they collectively recapitulate key fibrotic features, such as extracellular matrix remodeling, hepatic stellate cell activation, and collagen deposition, in a physiologically relevant 3D setting. In particular, multilineage liver organoids and assembloids integrate architectural complexity with scalability, enabling deeper mechanistic insights and supporting therapeutic evaluation with improved translational relevance. Conclusion: 3D in vitro liver models represent a promising strategy to bridge the gap between in vitro studies and in vivo realities by faithfully replicating liver-specific architecture and microenvironments. With enhanced reproducibility through standardized protocols, these models hold great potential for advancing drug discovery and facilitating the development of personalized therapies for liver fibrosis.

Original languageEnglish
Pages (from-to)593-609
Number of pages17
JournalTissue Engineering and Regenerative Medicine
Volume22
Issue number5
DOIs
Publication statusPublished - 2025 Jul

Bibliographical note

Publisher Copyright:
© Korean Tissue Engineering and Regenerative Medicine Society 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 3D in vitro liver models
  • Liver fibrosis
  • Organoids

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Recent Advances in Three-Dimensional In Vitro Models for Studies of Liver Fibrosis'. Together they form a unique fingerprint.

Cite this